Sana biotechnology, iaso biotherapeutics, and innovent biologics announce non-exclusive license agreement for clinically validated bcma car construct

Agreement combines iaso bio and innovent's car construct, validated in clinical trials, with sana's in vivo and ex vivo engineered cell therapy programs agreement combines iaso bio and innovent's car construct, validated in clinical trials, with sana's in vivo and ex vivo engineered cell therapy programs
SANA Ratings Summary
SANA Quant Ranking